RxDoctor Payments Data

Yolanda Rodriguez Valdivia, MD

Family Medicine · Pocatello, IDNPI 1093701351

Payments from drug & device makers

$440in general payments, 2019–2025

Across 20 payments — averaging $21.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$109
  • Novo Nordisk$52
  • Astellas Pharma US Inc$34
  • Inspire Medical Systems, Inc.$33
  • Amgen$33
  • Boston Scientific$32
  • plus $147 from 8 others

What the payments were for

  • Food & beverage$440100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$440 in reported general payments places this provider in the 55th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$88,239
Medicare patients
161
Services billed
1,111

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide94$107,282
MounjaroTirzepatide66$81,735
TrulicityDulaglutide28$34,338
XareltoRivaroxaban20$32,496
FarxigaDapagliflozin Propanediol19$31,046
JardianceEmpagliflozin21$26,124
JanuviaSitagliptin Phosphate30$25,614
EliquisApixaban21$25,204
JanumetSitagliptin Phos/Metformin Hcl15$21,575
LinzessLinaclotide19$21,181
MyrbetriqMirabegron17$7,246
Levothyroxine Sodium421$4,563
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$4,048
Venlafaxine Hcl ErVenlafaxine Hcl20$3,988
Duloxetine Hcl66$3,286

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$16$116,07394 claims
Novo NordiskOzempic$52$107,28294 claims
AbbVieLinzess, Synthroid$109$23,40745 claims
Astellas Pharma US IncMyrbetriq$34$7,24617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 803 family medicine providers in Idaho.

Other family medicine in Pocatello

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →